We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[The experience of using cellex in treatment of patients with acute ischemic stroke].
AIM: To evaluate the efficacy and safety of the combination of cellex with basic therapy in patients with ischemic stroke in the acute stage.
MATERIAL AND METHODS: An analytical prospective, randomized, simple, blind study included 52 patients with ischemic stroke. The main group of patients (n=26) was treated with basic therapy, which included hypotensive drugs, antiaggregants or anticoagulants depending on the concomitant pathology as well as vascular medications. In addition the patients received cellex in dose 0.1 mg daily during 10 days. The control group (n=26) received basic therapy. Along with assessment of neurological status, the Glasgow coma scale, the National Institute of Health stroke scale (NIHSS), the Barthel Index, the modified Rankin Scale, the MMSE, the Speech Function Score Scale, Speech Questionnaire were used on admission to the hospital, on the 5th, 10th day and on the day of discharge.
RESULTS AND CONCLUSION: A positive influence of cellex on the restoration of neurologic functions, mainly motor functions, was observed. Cellex has a good tolerability profile. The use of cellex together with basic therapy of ischemic stroke allows shortening the period of hospitalization.
MATERIAL AND METHODS: An analytical prospective, randomized, simple, blind study included 52 patients with ischemic stroke. The main group of patients (n=26) was treated with basic therapy, which included hypotensive drugs, antiaggregants or anticoagulants depending on the concomitant pathology as well as vascular medications. In addition the patients received cellex in dose 0.1 mg daily during 10 days. The control group (n=26) received basic therapy. Along with assessment of neurological status, the Glasgow coma scale, the National Institute of Health stroke scale (NIHSS), the Barthel Index, the modified Rankin Scale, the MMSE, the Speech Function Score Scale, Speech Questionnaire were used on admission to the hospital, on the 5th, 10th day and on the day of discharge.
RESULTS AND CONCLUSION: A positive influence of cellex on the restoration of neurologic functions, mainly motor functions, was observed. Cellex has a good tolerability profile. The use of cellex together with basic therapy of ischemic stroke allows shortening the period of hospitalization.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app